Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Am J Obstet Gynecol. 2017 May 31;217(4):478.e1–478.e8. doi: 10.1016/j.ajog.2017.05.050

Table 3.

Neonatal Morbidity in Women who Use Marijuana Compared to Non-Users

Neonatal Outcome
(Unweighted Sample Size)
Any Marijuana
Use
(N=48)
No Marijuana
Use
(N= 1562)
P value
Neonatal intensive care unit admission 16.9 9.5 0.12
Preterm delivery (<37 weeks) 17.3 9.0 0.07
Composite neonatal morbidity or death 14.1 4.5 0.002
  -Neonatal pulmonary morbidity 7.5 3.7 0.14
  -Necrotizing enterocolitis 0.4 0.2 0.33
  -Seizures 0.3 0.08 0.28
  -Retinopathy of prematurity 0.6 0.6 0.95
  -Neonatal infection morbidity 9.8 2.4 <.001
  -Anemia requiring blood transfusion 1.3 0.7 0.24
  -Neonatal surgery 0.3 0.8 0.37
  -Hyperbilirubinemia -0- 0.03 ---
  -Neonatal neurological morbidity 1.4 0.3 0.002
  -Neonatal death in L&D suite or prior to discharge 0.4 0.3 0.63

Composite neonatal morbidity includes indented list presented in remaining rows of table.

All results are reported as weighted percentages, p-value from weighted chi-square. The composite neonatal morbidity endpoint was defined by “any yes” or “all no”, as such some item non-response is present for individual components.